Uncategorized 彙整 - BRIM Biotechnology, Inc.

Category Uncategorized

A Team Approach to Translational Science

BRIM team chart

Success doesn’t just come from a winning idea or an exciting new concept.  Success comes from having a dedicated team behind that idea, with the enthusiasm and commitment to drive it from concept to clinic. The people behind the peptide…

BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome

Taipei, Taiwan, May 17th, 2022: BRIM Biotechnology, Inc. (“BRIM”) a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”) the world’s leading, ophthalmic research organization, for the late-stage…

A Peptide Approach to Regenerative Medicine

Are regenerative peptides the answer to current challenges in the development of treatments for unmet needs? In an article published in PharmaTimes Magazine, Frank Lee, CSO, and Maria Chen, VP of Business Development, discuss the potential of pigment epithelium-derived factor…

Download BRIM's Corporate Overview